We are one of only a few hospitals in the country offering a relatively new treatment option, called UroLift®, for men with benign prostatic hyperplasia (BPH).
The UroLift® system received NICE guidance approval in 2014, as a proven surgical option for the treatment of lower urinary tract symptoms due to an enlarged prostate due to BPH. The treatment works by using a number of tiny implants to lift and hold the enlarged prostate tissue out of the way so that it no longer blocks the urethra, resulting in improved urine flow.
UroLift® is unique in that it does not destroy the prostate tissue, meaning that it does not cause erectile dysfunction or permanent urinary incontinence. It is a minimally invasive procedure which can means patients can return home and to normal daily activities soon after treatment.
For men older than 50 years, benign prostatic hyperplasia (BPH) is a common prostate problem. UroLift® is an alternative for patients looking for something other than drug therapy or more invasive surgery. Treatment might be right for you if any of the following apply to you:
Typically you will be able to go home after the procedure without a catheter. You should experience rapid symptom relief without complications, as early as two weeks after the procedure. Results are long-lasting, with no medications required to sustain relief.
We offer competitive all-inclusive package prices making it easy to pay for your own treatment.
We have agreements in place with all of the major health insurance providers. So, if you are insured, please call your insurance company for authorisation.
Surgery that involves cutting both the tubes (vas) that carry sperm from the testicles.
More than two or three infections a year is viewed as ‘recurrent’ infections. If you are getting lots of infections then some simple tests can exclude any underlying abnormalities that are making them occur more often.
We are delighted and so proud to share that Jade has passed her final exam, achieving her AMSPAR Qualification. (The Association of Medical Secretaries, Practice Managers, Administrators and Receptionists).
Stourside and West Midlands Hospitlas are congratulating their Consultant Orthopaedic Hip & Knee Surgeon, Mr Sabur Malek, as he has been given the 'Hip and Knee Surgeon of the Year 2024' award in the GHP Private Healthcare Awards.
As part of the site developments at West Midlands Hospital, they have recently invested into opening a second laminar flow theatre.